Corient Private Wealth LP Buys 34,307 Shares of Aflac Incorporated $AFL
by Doug Wharley · The Cerbat GemCorient Private Wealth LP increased its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 7.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 496,085 shares of the financial services provider’s stock after purchasing an additional 34,307 shares during the quarter. Corient Private Wealth LP’s holdings in Aflac were worth $58,166,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Stephens Inc. AR raised its holdings in Aflac by 0.4% in the fourth quarter. Stephens Inc. AR now owns 21,945 shares of the financial services provider’s stock worth $2,420,000 after purchasing an additional 91 shares in the last quarter. Compound Planning Inc. lifted its position in shares of Aflac by 0.7% during the first quarter. Compound Planning Inc. now owns 13,743 shares of the financial services provider’s stock valued at $1,508,000 after buying an additional 91 shares during the last quarter. Root Financial Partners LLC boosted its holdings in shares of Aflac by 4.5% in the 4th quarter. Root Financial Partners LLC now owns 2,119 shares of the financial services provider’s stock valued at $234,000 after buying an additional 92 shares in the last quarter. HBK Sorce Advisory LLC boosted its holdings in shares of Aflac by 1.2% in the 4th quarter. HBK Sorce Advisory LLC now owns 7,702 shares of the financial services provider’s stock valued at $902,000 after buying an additional 95 shares in the last quarter. Finally, Studio Investment Management LLC boosted its holdings in shares of Aflac by 1.3% in the 2nd quarter. Studio Investment Management LLC now owns 7,650 shares of the financial services provider’s stock valued at $897,000 after buying an additional 96 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.
Wall Street Analysts Forecast Growth
AFL has been the subject of several recent analyst reports. Keefe, Bruyette & Woods boosted their price objective on shares of Aflac from $120.00 to $125.00 and gave the stock a “market perform” rating in a research note on Tuesday, August 11th. TD Cowen restated a “hold” rating and issued a $110.00 target price (up from $101.00) on shares of Aflac in a research note on Wednesday, July 22nd. Wall Street Zen lowered shares of Aflac from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. UBS Group reaffirmed a “neutral” rating and set a $124.00 price target (up from $114.00) on shares of Aflac in a research report on Wednesday, July 8th. Finally, Wells Fargo & Company set a $122.00 price target on Aflac and gave the stock an “equal weight” rating in a research report on Wednesday, August 19th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, Aflac currently has a consensus rating of “Hold” and a consensus target price of $116.62.
Read Our Latest Report on Aflac
Insider Buying and Selling
In related news, major shareholder Post Holdings Co. Ltd. Japan sold 13,600 shares of the stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $115.44, for a total value of $1,569,984.00. Following the transaction, the insider owned 50,625,490 shares in the company, valued at approximately $5,844,206,565.60. This represents a 0.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 375,815 shares of company stock valued at $44,190,500 in the last 90 days. 0.80% of the stock is owned by corporate insiders.
Aflac Stock Performance
Shares of AFL opened at $115.28 on Friday. The stock has a 50-day moving average of $121.08 and a two-hundred day moving average of $116.31. Aflac Incorporated has a one year low of $105.43 and a one year high of $130.22. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.12 and a current ratio of 0.12. The stock has a market cap of $57.79 billion, a P/E ratio of 12.36, a P/E/G ratio of 1.86 and a beta of 0.59.
Aflac (NYSE:AFL – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The financial services provider reported $1.75 earnings per share for the quarter, missing the consensus estimate of $1.76 by ($0.01). The firm had revenue of $4.22 billion for the quarter, compared to analysts’ expectations of $4.11 billion. Aflac had a net margin of 26.91% and a return on equity of 13.27%. The firm’s revenue for the quarter was down 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.78 EPS. As a group, research analysts predict that Aflac Incorporated will post 7.04 EPS for the current year.
Aflac Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 1st. Investors of record on Wednesday, August 19th were given a $0.61 dividend. The ex-dividend date was Wednesday, August 19th. This represents a $2.44 dividend on an annualized basis and a yield of 2.1%. Aflac’s dividend payout ratio is currently 26.15%.
About Aflac
Aflac Incorporated is an insurance company that provides supplemental health and life insurance products. Its coverage is designed to help policyholders manage expenses that may not be fully covered by major medical insurance, including costs associated with accidents, illness, hospitalization, disability and critical illness.
Through its U.S. operations, Aflac markets policies to individuals, businesses and employees through workplace benefit programs, independent agents and brokers. The company is also a major provider of supplemental insurance in Japan, where it offers products focused primarily on cancer, medical and income-support coverage.
Founded in 1955 in Columbus, Georgia, as American Family Life Assurance Company, the business adopted the name Aflac in 1990.
Featured Stories
- Five stocks we like better than Aflac
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).